Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Annals of Surgical Oncology
|
May 1, 1996
Immunological memory induced by genetically transduced tumor cells
M M Dar, Z Abdel-Wahab, C E Vervaert, et al.
Cellular Immunology
|
August 1, 1996
Effect of irradiation on cytokine production, MHC antigen expression, and vaccine potential of interleukin-2 and interferon-gamma gene-modified melanoma cells
Z Abdel-Wahab, M M Dar, D Hester, et al.
Clinical Pharmacology and Therapeutics
|
October 29, 2010
A phase I study of the pharmacokinetic and safety profiles of oral pazopanib with a high-fat or low-fat meal in patients with advanced solid tumors
E I Heath, E G Chiorean, C J Sweeney, et al.
Clinical Pharmacology and Therapeutics
|
October 1, 2010
An evaluation of the drug interaction potential of pazopanib, an oral vascular endothelial growth factor receptor tyrosine kinase inhibitor, using a modified Cooperstown 5+1 cocktail in patients with advanced solid tumors
B C Goh, N J Reddy, U B Dandamudi, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
March 14, 2009
Bioequivalence study of a new oral topotecan formulation, relative to the current topotecan formulation, in patients with advanced solid tumors
R L Oostendorp, J Loftiss, S Goel, et al.
British Journal of Cancer
|
March 6, 2008
A phase I trial of ispinesib, a kinesin spindle protein inhibitor, with docetaxel in patients with advanced solid tumours
S P Blagden, L R Molife, A Seebaran, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Annals of Surgical Oncology
|
May 1, 1996
Immunological memory induced by genetically transduced tumor cells
M M Dar, Z Abdel-Wahab, C E Vervaert, et al.
Cellular Immunology
|
August 1, 1996
Effect of irradiation on cytokine production, MHC antigen expression, and vaccine potential of interleukin-2 and interferon-gamma gene-modified melanoma cells
Z Abdel-Wahab, M M Dar, D Hester, et al.
Clinical Pharmacology and Therapeutics
|
October 29, 2010
A phase I study of the pharmacokinetic and safety profiles of oral pazopanib with a high-fat or low-fat meal in patients with advanced solid tumors
E I Heath, E G Chiorean, C J Sweeney, et al.
Clinical Pharmacology and Therapeutics
|
October 1, 2010
An evaluation of the drug interaction potential of pazopanib, an oral vascular endothelial growth factor receptor tyrosine kinase inhibitor, using a modified Cooperstown 5+1 cocktail in patients with advanced solid tumors
B C Goh, N J Reddy, U B Dandamudi, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
March 14, 2009
Bioequivalence study of a new oral topotecan formulation, relative to the current topotecan formulation, in patients with advanced solid tumors
R L Oostendorp, J Loftiss, S Goel, et al.
British Journal of Cancer
|
March 6, 2008
A phase I trial of ispinesib, a kinesin spindle protein inhibitor, with docetaxel in patients with advanced solid tumours
S P Blagden, L R Molife, A Seebaran, et al.
Page
of 1